AtaiBeckley (ATAI) Tax Provisions (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Tax Provisions came in at $20000.0 in Q1 2026, down 87.18% year-on-year from $156000.0 in Q1 2025, and down 87.18% quarter-over-quarter from $156000.0 in Q1 2025.
AtaiBeckley (ATAI) Tax Provisions (2020 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of Tax Provisions data on file, last reported at $100000.0 in Q3 2025.
- For the quarter ending Q3 2025, Tax Provisions fell 50.0% year-over-year to $100000.0; the trailing twelve-month figure through Sep 2025 stood at $163000.0 (down 74.65% YoY), and the FY2024 full-year result was -$356000.0, down 135.04% from the prior year.
- Tax Provisions slipped to $20000.0 in Q1 2026 per ATAI's latest filing, from $156000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $156000.0 in Q1 2025 and bottomed at $20000.0 in Q1 2026.
- A 5-year average of $197736.8 and a median of $100000.0 in 2022 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions soared 9900.0% in 2021 and sank 145.09% in 2024, its largest moves.
- Tracing ATAI's Tax Provisions over 5 years: stood at $717000.0 in 2021, then soared by 33.19% to $955000.0 in 2022, then slumped by 55.18% to $428000.0 in 2023, then slumped by 145.09% to -$193000.0 in 2024, then surged by 151.81% to $100000.0 in 2025.
- Business Quant data shows ATAI's Tax Provisions at $100000.0 in Q3 2025, $100000.0 in Q2 2025, and $156000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Dec 31, 2024 | -193,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | 428,000.00 |
| Sep 30, 2023 | 238,000.00 |
| Jun 30, 2023 | 185,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 955,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 41,000.00 |
| Dec 31, 2021 | 717,000.00 |
| Sep 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 58,000.00 |